The Link Between Streptococcus bovis and CRC
Presence of a particular biotype of the Streptococcus bovis bacterium can be an indicator of a GI malignancy.
Presence of a particular biotype of the Streptococcus bovis bacterium can be an indicator of a GI malignancy.
Lifestyle factors have contributed to the rising incidence of esophageal carcinoma—but there are other risk factors that come into play as well.
Clinicians should be aware of the basic diagnostic work-up as well as the appropriate follow-up plan for potentially malignant neoplastic pancreatic cysts.
Crohn’s disease can be challenging to manage, and make come with an increased risk for cancer.
Bowel preparation plays a key role in deciding when to schedule follow-up screening for colorectal cancer.
Caused by chemotherapeutic agents and malignancies alike, neutropenic enterocolitis is a side effect that can lead to significant patient morbidity.
EUS-CNB may offer a viable technique for managing pain in patients with pancreatic cancer.
There are both advantages and disadvantages to using CA 19-9 to screen and monitor patients with pancreatic cancer.
Sorafenib can be an effective treatment for a variety of cancers, but its use can come with significant GI side effects.
Chemotherapy can result in a number of adverse side effects, the most common being elevated liver function tests.